199 related articles for article (PubMed ID: 1173307)
1. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
Seki K; Seki M; Okumura T
Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
3. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
[TBL] [Abstract][Full Text] [Related]
4. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
Mroueh AM; Siler-Khodr TM
Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
[TBL] [Abstract][Full Text] [Related]
5. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
Lloyd SJ; Josimovich JB; Archer DF
Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
[TBL] [Abstract][Full Text] [Related]
6. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
Künzig HJ; Geiger W; Schulz KD; Lose KH
Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
Aono T; Shioji T; Kohno M; Ueda G; Kurachi K
Fertil Steril; 1976 Mar; 27(3):341-4. PubMed ID: 943332
[TBL] [Abstract][Full Text] [Related]
8. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
Dickey RP; Stone SC
Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
[TBL] [Abstract][Full Text] [Related]
9. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
March CM; Kletzky OA; Davajan V
Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
Farrari C; Telloli P; Rampini P; Caldara R
Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
[TBL] [Abstract][Full Text] [Related]
12. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
[TBL] [Abstract][Full Text] [Related]
13. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
Mroueh AM; Siler-Khodr TM
J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
[TBL] [Abstract][Full Text] [Related]
14. Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhoea.
Beumont P; Bruwer J; Pimstone B; Vinik A; Utian W
Br J Psychiatry; 1975 Mar; 126():285-8. PubMed ID: 236061
[No Abstract] [Full Text] [Related]
15. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
Netter A; Netter AL; Gorins A
Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
[No Abstract] [Full Text] [Related]
16. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
de Bernal M; de Villamizar M
Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
[TBL] [Abstract][Full Text] [Related]
17. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
Schellekens LA; Roland R; Lequin RM
Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
[No Abstract] [Full Text] [Related]
19. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
Shapiro AG
South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
[TBL] [Abstract][Full Text] [Related]
20. Treatment of functional amenorrhea-galactorrhea with 2-bromoergocryptine.
Wiebe RH; Hammond CB; Handwerger S
Fertil Steril; 1977 Apr; 28(4):426-33. PubMed ID: 321260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
